These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 14655145
1. PCNA and laminin as prognostic factors in primary Fallopian tube carcinoma. Hałoń A, Rabczyński J. Folia Morphol (Warsz); 2003 Nov; 62(4):475-8. PubMed ID: 14655145 [Abstract] [Full Text] [Related]
3. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma. Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M. Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668 [Abstract] [Full Text] [Related]
4. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival. Nakamura T, Tabuchi Y, Nakae S, Ohno M, Saitoh Y. Cancer; 1996 Apr 15; 77(8 Suppl):1741-6. PubMed ID: 8608572 [Abstract] [Full Text] [Related]
5. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma. Wang LF, Chai CY, Kuo WR, Tai CF, Lee KW, Ho KY. Am J Otolaryngol; 2006 Apr 15; 27(2):101-5. PubMed ID: 16500472 [Abstract] [Full Text] [Related]
6. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Ajiki T, Kamigaki T, Hasegawa Y, Fujino Y, Suzuki Y, Takeyama Y, Ku Y, Kuroda Y. Hepatogastroenterology; 2001 Apr 15; 48(41):1266-70. PubMed ID: 11677943 [Abstract] [Full Text] [Related]
7. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast. Aziz SA, Pervez S, Khan SM, Kayani N, Nasir MI. J Coll Physicians Surg Pak; 2005 Apr 15; 15(4):225-9. PubMed ID: 15857596 [Abstract] [Full Text] [Related]
14. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma]. Reitmaier M, Rudlowski C, Biesterfeld S, Rath W, Schröder W. Zentralbl Gynakol; 2000 Apr 15; 122(7):361-7. PubMed ID: 10951706 [Abstract] [Full Text] [Related]
16. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma. Wang LF, Chai CY, Kuo WR, Tai CF, Lee KW, Ho KY. Acta Otolaryngol; 2006 Jul 15; 126(7):769-74. PubMed ID: 16803719 [Abstract] [Full Text] [Related]
17. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance]. Tejido Sánchez A, Sánchez Chapado M, Rosino Sánchez A, Passas Martínez J, Bethencourt Codes F, Ruiz Ramos P, Leiva Galvis O. Arch Esp Urol; 2002 Apr 15; 55(3):257-65. PubMed ID: 12068757 [Abstract] [Full Text] [Related]
18. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Sharma M, Ralte A, Arora R, Santosh V, Shankar SK, Sarkar C. Pathology; 2004 Apr 15; 36(2):139-44. PubMed ID: 15203749 [Abstract] [Full Text] [Related]
19. Gastric carcinoma: recent issues in prognostic factors. Chen BF, Marrogi AJ, Freeman SM, Clejan S. J La State Med Soc; 1995 Apr 15; 147(4):138-45. PubMed ID: 7775839 [Abstract] [Full Text] [Related]
20. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ. J Exp Clin Cancer Res; 2004 Jun 15; 23(2):277-83. PubMed ID: 15354413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]